Companies tend to release quarterly toward end of the month, they don't wait to release any new announcement in the quarterly. If there are any clinical trial update, they will release it when available and not because of the quarterly. IMU has planned for Ph2 clinical trial this year so the Ph1 clinical trial will be completed this year which is in line with the usually timeframe for Ph1 clinical trial.
IMU Price at posting:
4.3¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)